Diabetes is Not Significantly Associated with Decreased First-Line Tuberculosis Drug Exposure

被引：0
|
作者：
Sturdy, Ann [1 ]
Romano, Federico [2 ]
Kipper, Karin [3 ]
Barrett, Jessica [1 ]
Whittington, Ashley [4 ]
Kon, Onn Min [1 ]
Oliver, Nick [1 ]
Pasca, Oscar Della
Cooke, Graham
机构：
[1] Imperial Coll London, Fac Med, London, England
[2] Univ Coll London UCL, Sch Pharm, London, England
[3] Epilepsy Soc, Analyt Chem Dept, London, England
[4] Northwick Pk Hosp & Clin Res Ctr, Dept Infect Dis, HARROW, England
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2025年 / 152卷
关键词：
D O I：
10.1016/j.ijid.2024.107549
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：43 / 44
页数：2
相关论文
共 50 条
  • [31] Challenges to replace ACT as first-line drug
    Phyo, Aung Pyae
    von Seidlein, Lorenz
    MALARIA JOURNAL, 2017, 16
  • [32] Challenges to replace ACT as first-line drug
    Aung Pyae Phyo
    Lorenz von Seidlein
    Malaria Journal, 16
  • [33] First-line antiretroviral drug discontinuations in children
    Fortuin-de Smidt, Melony
    de Waal, Renee
    Cohen, Karen
    Technau, Karl-Gunter
    Stinson, Kathryn
    Maartens, Gary
    Boulle, Andrew
    Igumbor, Ehimario U.
    Davies, Mary-Ann
    PLOS ONE, 2017, 12 (02):
  • [34] Magnitude of Phenotypic and MTBDRplus Line Probe Assay First-Line Anti-Tuberculosis Drug Resistance Among Tuberculosis Patients; Northwest Ethiopia
    Yigzaw, Wubet Birhan
    Torrelles, Jordi B.
    Wang, Shu-Hua
    Tessenna, Belay
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 497 - 505
  • [35] First-line renin–angiotensin system inhibitors vs. other first-line antihypertensive drug classes in hypertensive patients with type 2 diabetes mellitus
    Ganmi Wang
    Yujie Chen
    Liangjin Li
    Wenlu Tang
    James M. Wright
    Journal of Human Hypertension, 2018, 32 : 494 - 506
  • [36] Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring
    Verbeeck, Roger K.
    Guenther, Gunar
    Kibuule, Dan
    Hunter, Christian
    Rennie, Tim W.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (08) : 905 - 916
  • [37] Dynamics of Tuberculosis (TB) with Drug Resistance to First-Line Treatment and Leaky Vaccination: A Deterministic Modelling Perspective
    Otoo, Dominic
    Osman, Shaibu
    Poku, Stephen Atta
    Donkoh, Elvis Kobina
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2021, 2021
  • [38] Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru
    Schwalb, Alvaro
    Cachay, Rodrigo
    Meza, Ericka
    Caceres, Tatiana
    Blackman, Amondrea
    Maruri, Fernanda
    Sterling, Timothy R.
    Gotuzzo, Eduardo
    BMC RESEARCH NOTES, 2021, 14 (01)
  • [39] Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring
    Roger K. Verbeeck
    Gunar Günther
    Dan Kibuule
    Christian Hunter
    Tim W. Rennie
    European Journal of Clinical Pharmacology, 2016, 72 : 905 - 916
  • [40] Cost of managing severe cutaneous adverse drug reactions to first-line tuberculosis therapy in South Africa
    Knight, Lauren K.
    Lehloenya, Rannakoe J.
    Sinanovic, Edina
    Pooran, Anil
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2019, 24 (08) : 994 - 1002
12345